The dysregulation of cholesterol metabolism and inflammation plays a significant role in the progression of diabetic nephropathy (DN). Anthocyanins are polyphenols widely distributed in food and exert various biological effects including antioxidative, anti-inflammatory, and antihyperlipidemic effects. However, it remains unclear whether anthocyanins are associated with DN, and the mechanisms involved in the reciprocal regulation of inflammation and cholesterol efflux are yet to be elucidated. In this study, we evaluated the regulation of cholesterol metabolism and the antiinflammatory effects exerted by anthocyanins (cyanidin-3-O-β-glucoside chloride [C3G] or cyanidin chloride [Cy]) and investigated the underlying molecular mechanism of action using high-glucose (HG)-stimulated HK-2 cells. We found that anthocyanins enhanced cholesterol efflux and ABCA1 expression markedly in HK-2 cells. In addition, they increased peroxisome proliferator-activated receptor alpha (PPARα) and liver X receptor alpha (LXRα) expression and decreased the HG-induced expression of the proinflammatory cytokines intercellular adhesion molecule-1 (ICAM1), monocyte chemoattractant protein-1 (MCP1), and transforming growth factor-β1 (TGFβ1), as well as NFκB activation. Incubation with the PPARα-specific inhibitor GW6471 and LXRα shRNA attenuated the anthocyanin-mediated promotion of ABCA1 expression and cholesterol efflux, suggesting that anthocyanins activated PPARα-LXRα-ABCA1-dependent cholesterol efflux in HK-2 cells. Moreover, the knockout of LXRα abrogated the anti-inflammatory effect of anthocyanins, whereas the PPARα antagonist GW6471 does not have this effect. Further investigations revealed that LXRα might interfere with anthocyanin-induced decreased ICAM1, MCP1, and TGFβ1 expression by reducing the nuclear translocation of NFκB. Collectively, these findings suggest that blocking cholesterol deposition and inhibiting the LXRα pathway-induced inflammatory response might be one of the main mechanisms by which anthocyanins exert their protective effects in DN.
Introduction
Diabetes mellitus (DM), which is characterized by long-term hyperglycemia and various diabetes-related complications, is currently a major worldwide epidemic. Of all the important and serious complications, diabetic nephropathy (DN) has become the leading cause of endstage renal disease, and contributes profoundly to patient morbidity and mortality. 1 Although hyperglycemia and hypertension play key roles in the pathogenesis of DN, potential additional risk factors and the underlying mechanisms behind these effects remain unclear. Moreover, current therapies, including strict glycemic control, intensive insulin treatment, and reduction of hypertension, delay the progression of DN, but do not sufficiently prevent progression to end-stage renal disease. 2 Therefore, clarifying novel pathogenic mechanisms and exploring additional effective therapeutic strategies is needed urgently.
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Hyperglycemia is a primary risk factor for DN, and sustained hyperglycemia promotes lipid accumulation and inflammatory infiltration in the kidneys of patients with type 2 DM. Recently, the intrarenal accumulation of lipids and proinflammatory cytokines was observed in diabetic humans and experimental animal models. [3] [4] [5] Lipotoxicity and inflammation might play an important role in the pathogenesis of DN. Accumulating evidence has suggested that monocyte chemoattractant protein-1 (MCP1), 6 transforming growth factor-β1 (TGFβ1), 7, 8 and intercellular adhesion molecule-1 (ICAM1) 9 are important proinflammatory cytokines involved in the development of DN. In addition, activated nuclear factor-κB (NFκB) translocates from the cytoplasm to the nucleus to trigger the expression of its target genes including MCP1, ICAM1, and TGFβ1 to induce persistent and enhanced inflammation, which leads to glomerulosclerosis and tubulointerstitial fibrosis. [10] [11] [12] [13] Dysregulated cholesterol metabolism has also been linked to lipid accumulation and inflammation in diabetes. Ruan et al 14 showed that interleukin 1β (IL-1β) promotes intracellular lipid accumulation in mesangial cells by inhibiting cholesterol efflux. In addition, cholesterol accumulation and ABCA1 downregulation in podocytes plays a pathogenic role in DN. 15 ABCA1, a member of the ATP-binding cassette transporter family, facilitates the efflux of cellular cholesterol to extracellular apoA1 or high-density lipoprotein (HDL). ABCA1 expression was reduced in the kidneys of diabetic NOD mice, which was accompanied by increased levels of renal cholesterol. 16 Acute renal tubular injury can also trigger the downregulation of ABCA1 and cholesterol accumulation. 17 Numerous studies reveal that peroxisome proliferatoractivated receptor alpha (PPARα) and liver X receptor alpha (LXRα), which are upstream of ABCA1, activate a transcriptional cascade to modulate the expression of ABCA1 and cholesterol efflux. 18, 19 High-glucose (HG) was sufficient to downregulate PPARα and LXRα expression, which was associated with severe dyslipidemia and inflammation in diabetic kidneys. 3, 20 The increase in PPARα expression reduces triglycerides, total cholesterol, and low-density lipoprotein (LDL) levels markedly, and elevates high-density lipoprotein (HDL) levels. PPARα deficiency accelerates dyslipidemia in animal models of DN. 21 A study by Johnston and Waxman 22 demonstrated that PPARα could increase the expression of LXRα in macrophages and thereby promote the expression of ABCA1, which subsequently mediates cholesterol efflux to apoA1. In addition to their important role in regulating lipid metabolism, PPARα and LXRα exhibit anti-inflammatory effects in many inflammatory and metabolic diseases. Recent studies found that the PPARα activator fenofibrate ameliorates inflammation by inhibiting NFκB activity and suppressing the production of the proinflammatory cytokines ICAM1, TGFβ1, and MCP1. 23, 24 The activation of LXRα also inhibits the production of the proinflammatory cytokines MCP1, 25 ICAM1, 26 and TGFβ1. 27 Thus, PPARα and LXRα are physiological regulators that lie at the intersection of lipid metabolism and inflammation.
In recent years, the ingestion of naturally grown fresh vegetables, fruits, and crops was revealed to have preventive effect in diabetes and its complications. 28 For example, anthocyanins are the largest group of water-soluble pigments, and belong to the family of phenolic flavonoid compounds that are responsible for the blue, red, purple, and pink colors of many plants in nature. Anthocyanins exhibit powerful antioxidative properties in diabetic animal models and also exert protective effects against hyperglycemia-induced kidney injury. 29 In addition, many studies suggested that anthocyanins also have anti-inflammatory and antihyperlipidemic effects. Purple corn anthocyanins (PCA) prevent HG-induced glomerulosclerosis and renal fibrosis via NFκB-dependent mechanisms. 8 Anthocyanin-rich foods and extracts increase ABCA1 levels significantly and suppress cholesterol accumulation in the liver and aorta. 30, 31 However, no studies have revealed the mechanisms involved in the reciprocal regulation of inflammation and cholesterol efflux by anthocyanins in DN.
In this study, we examined the effect of anthocyanins (cyanidin-3-O-β-glucoside chloride [C3G] and cyanidin chloride [Cy] , an aglycon of C3G; Figure 1 ) on HG-mediated cholesterol accumulation and inflammation, as well as their possible molecular mechanism of action in HK-2 cells.
Materials and methods
All procedures were performed in compliance with the guidelines established by the Ethics Review Committee for Experimentation of Hebei Medical University. cell culture HK-2 cells were obtained from ATCC (American Type Culture Collection, Manassas, VA, USA). They were cultured in Dulbecco's Modified Eagle's Medium/Nutrient Mixture F-12 (DMEM-F12, 3:1) supplemented with 10% fetal bovine serum in a humidified 5% CO 2 atmosphere at 37°C. Cells were made quiescent by culturing in serum-free medium for 24 hours (h). According to the different experiments, HK-2 cells were pretreated with or without C3G or Cy (50 µM) for 1 h, before exposure to HG (30 mM) for 24 or 48 h. Additional cells were stimulated with normal glucose (NG) (5.6 mM) as a normal control, and NG plus mannitol (24.4 mM) as an osmotic control. In the experiments intended to evaluate the specific involvement of PPARα in the activation of its target genes, cells were treated with 25 µM GW6471, a PPARα antagonist, 30 minutes (min) before the treatment with anthocyanins. All cell experiments were repeated at least three times.
cell viability
MTT assays were used to determine the effects of C3G and Cy on cell viability. HK-2 cells in 96 well plates were exposed to HG (30 mM) alone for 24 h or preincubated with different concentrations of C3G and Cy (0-100 µM) for 1 h, followed by stimulation with or without HG (30 mM) for 24 h. Subsequently, 20 µL MTT (5 mg/mL) was added to each well, and the cells were further incubated for an additional 4 h. The supernatant was removed and the formazan crystals were dissolved with 150 µL/well of DMSO. The optical density was measured at 570 nm using a microplate reader (Synergy 2; BioTek, Winooski, VT, USA).
Flow cytometry
To assess the effect of anthocyanins on HG-induced intracellular reactive oxygen species (ROS) generation in HK-2 cells, flow cytometry with CM-DCHF-DA (CM-DCHF-DA″ is chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate; Invitrogen) was used to evaluate the changes in hydroxyl radicals quantitatively. Briefly, cells were grown to 60%-70% confluence, and then incubated under the different experimental conditions in 6 well plates for 48 h. The media was then replaced with fresh serum-free media containing 10 µM DCHF-DA at 37°C for 30 min. Thereafter, cells were washed, trypsinized, and suspended in 500 µL phosphate-buffered saline (PBS), and the fluorescence intensity was measured immediately using a flow cytometer (BD Immunocytometry Systems, Franklin Lakes, NJ, USA).
Transient transfection
HK-2 cells were transfected transiently using FuGENE-HD transfection reagent according to the manufacturer's instructions. Cells were seeded in 6 well plates at 80% confluence, and then transfected with 3.0 µg pLV-NR1H3-shRNA plasmid or scrambled control shRNA plasmid with 9 µL transfection reagent in 2 mL normal DMEM-F12 (3:1) medium. After 24 h, the cells were washed once with serum-free DMEM-F12 (3:1) medium, treated with HG or HG plus anthocyanins for 48 h, and then analyzed using Western blotting and filipin staining.
elisa assay
The supernatants from different groups of cells were collected and the concentrations of the proinflammatory cytokines, ICAM1, MCP1, and TGFβ1, were quantified using commercially available ELISA kits (Neobioscience), according to the manufacturer's instructions.
Western blotting
Nuclear and cytoplasmic proteins were extracted from HK-2 cells using a Nuclear and Cytoplasmic Protein Extraction Kit (Invitrogen). Proteins (50 µg/lane) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). The membranes were incubated overnight at 4°C with anti-ABCA1, -PPARα, -LXRα, -MCP1, -ICAM1, -TGFβ1, -β-actin, and -histone H3 Drug Design, Development and Therapy 2015:9 submit your manuscript | www.dovepress.com
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Du et al antibodies. Next, the membranes were incubated with goat anti-rabbit or mouse IgG horseradish peroxidase-conjugated secondary antibodies, and then scanned using an Odyssey Fc System (LI/-COR; Amersham, Piscataway, NJ, USA). The intensity of the bands was measured using LabWorks 4.5 software (UVP, Upland, CA, USA).
rna isolation and quantitative real-time polymerase chain reaction (rT-qPcr)
Total RNA and cDNA were prepared from cultured cells using TRIzol reagent (Invitrogen) and a TaKaRa RNA PCR kit (AMV) version 3.0 (TaKaRa Bio Inc.), respectively. cDNA was amplified using PCR with specific primers for PPARα, LXRα, ABCA1, MCP1, ICAM1, TGFβ1, and 18s rRNA (Table 1) . RT-qPCR was performed using SYBR Premix Ex TaqTMII and an Agilent Mx3000P QPCR System (Agilent, CA, USA). The relative changes in gene expression were calculated using the 2 -ΔΔCT method, and all experiments were repeated at least thrice.
Oil red O staining
HK-2 cells were allowed to adhere to polylysine-coated coverslips and grown for 24 h. Cells were pretreated with or without C3G or Cy (50 µM) for 1 h, and then exposed to HG (30 mM) for 24 or 48 h. Subsequently, total cellular cholesterol was measured using Oil Red O staining. Cells were fixed in 4% paraformaldehyde in PBS for 30 min and then stained for 15 min in 1% Oil Red O dissolved in 60% isopropanol. Then, the sections were washed with 70% alcohol for 5 seconds (s) to remove background staining. Finally, the cells were rinsed in tap water and counterstained with Harris hematoxylin for 10 s. The stained sections were imaged with an Olympus microscope (Olympus Corporation, Tokyo, Japan).
Cholesterol efflux assays
Cholesterol levels were assayed using an Amplex Red Cholesterol Assay kit (Molecular Probes; Invitrogen) according to the manufacturer's instructions. Briefly, HK-2 cells were treated as described above in 96 well plates, and then 50 µL Amplex Red reagent was added. After 45 min incubation at 37°C in the dark, sample fluorescence was measured using a microplate reader (Synergy 2; BioTek) with excitation at 530/525 nm and emission at 590/535 nm. Both the extracellular (in the growth medium) and intracellular cholesterol were analyzed. Cholesterol esterase was omitted from the assay. Each sample was analyzed in triplicate, and at least three independent experiments were performed. immunocytochemistry Endogenous peroxidase activity was blocked using 3% hydrogen peroxide for 10 min, and the cells were incubated overnight at 4°C with anti-NFκB p65 (1:100) monoclonal antibody. Subsequently, the cells were incubated with biotin-labeled anti-rabbit IgG for 1 h, and then stained using a streptavidinperoxidase detection system. Negative control samples were incubated with PBS instead of the primary antibody.
statistical analysis
Values are expressed as means ± SDs. Significant differences between groups were determined using one-way analysis of variance using SAS software (release 8.01; SAS Institute, Inc., Cary, NC, USA); P0.05 was considered to be statistically significant.
Results
effect of anthocyanins on cell viability and radical scavenging
The potential cytotoxic effects of anthocyanins were evaluated first using MTT assays. The results showed that C3G and Cy did not affect the viability of HK-2 cells at the concentrations used (10, 20 , and 50 µM; Figure 2A and B). Thus, C3G and Cy did not have cytotoxic effects in HK-2 cells. Because anthocyanins have powerful antioxidative properties, we next evaluated whether C3G and Cy reduced HG-induced ROS production in HK-2 cells, and the doses required for these effects. As shown in Figure 2C and D, HG increased intracellular ROS levels significantly, and this effect was reduced by C3G and Cy in a dose-dependent manner. These results indicate that C3G and Cy could reduce the intracellular ROS levels effectively 
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Protective effects of anthocyanins in diabetic nephropathy in a dose-dependent manner under HG conditions. Taken together with the results of MTT assays, we selected the dose of 50 µM of anthocyanins for use in subsequent experiments. In addition, mannitol had no effect on ROS levels.
Anthocyanins enhance cholesterol efflux and aBca1 expression in hg-stimulated hK-2 cells
To determine whether anthocyanins weakened or prevented HG to decrease cholesterol efflux, we first analyzed cholesterol levels inside the cell using Oil Red O staining. Compared with the NG groups, HG enhanced cholesterol levels significantly inside the cell after treatment for 24 h, and this continued to increase until 48 h. In contrast, treatment with C3G and Cy markedly attenuated HG-induced cholesterol levels increasing inside the cell ( Figure 3A) . Next, we investigated the changes in cholesterol concentrations in the culture media and inside the cell using cholesterol efflux analysis. The results were consistent with Oil Red O staining ( Figure 3B and C) .
Because ABCA1 is important for cholesterol efflux, 16 we next examined the effect of anthocyanins on ABCA1 expression. The mRNA and protein levels of ABCA1 significantly decreased after treatment with HG for 24 h, and remained at low levels until 48 h. Treatment with C3G and Cy reversed the HG-induced decrease in ABCA1 markedly ( Figure 3D and E) . These results suggest that anthocyanins enhanced cholesterol efflux from HK-2 cells by upregulating ABCA1.
anthocyanins increase the gene expression of PParα and lXrα in hg-stimulated hK-2 cells reversed the effects of anthocyanins on ABCA1 expression ( Figure 6B and C) and cholesterol efflux ( Figure 6D ). These results indicate that anthocyanins increase ABCA1 expression and cholesterol efflux via an LXRα-dependent pathway.
effects of anthocyanins on cytokine production in hg-stimulated hK-2 cells
To analyze the anti-inflammatory effects of anthocyanins in the progression of the DN, we measured the protein and mRNA levels of ICAM1, MCP1, and TGFβ1 using Western blotting, quantitative real-time (qRT)-PCR, and ELISA. Western blotting analysis revealed that HG increased the protein levels of ICAM1, MCP1, and TGFβ1 at 24 and 48 h significantly compared with NG group. In contrast, these HGinduced increases were decreased significantly by C3G and Cy ( Figure 7A ). The results of qRT-PCR ( Figure 7B ) and ELISA ( Figure 7C ) were consistent with these observations.
The anthocyanin-induced reduction in icaM1, McP1, and TgFβ1 expression is dependent on the activation of lXrα, but not PParα
Recent reports [22] [23] [24] [25] [26] demonstrated that PPARα and LXRα mediated the expression of some inflammatory cytokines. Therefore, we next investigated the possible effects of PPARα and LXRα on the inhibition of HG-mediated inflammatory signaling by anthocyanins. First, HK-2 cells were transfected with pLV-NR1H3-shRNA plasmid and then incubated with HG in the presence or absence of C3G or Cy for 48 h. Compared with the anthocyanin treatment groups, transfection with pLV-NR1H3-shRNA reversed the effects of anthocyanins on HG-induced ICAM1, MCP1, and TGFβ1 expression significantly ( Figure 8A and B) . Next, we used the specific PPARα inhibitor GW6471 to observe the role of PPARα in the anthocyanin-mediated inhibition of HG-induced ICAM1, MCP1, and TGFβ1 expression. Co-pretreatment with 25 µM GW6471 and C3G or Cy for 48 h slightly reversed the inhibitory effects of C3G or Cy on HG-induced ICAM1, MCP1, and TGFβ1 expression ( Figure 8A and B) . These results suggest that anthocyanins decreased the expression of ICAM1, MCP1, and TGFβ1 by upregulating LXRα transcriptional activity, but not PPARα.
effects of anthocyanins on nFκB activation in hg-stimulated hK-2 cells
As shown in Figure 9 , HG enhanced the nuclear and decreased the cytoplasmic localization of NFκB p65 (P0.05). However, HG-induced NFκB p65 nuclear translocation was attenuated by C3G and Cy (I0.05), which suggests that the anti-inflammatory effects of anthocyanins are most likely mediated by NFκB signaling.
anthocyanin-induced nFκB activity reduces cytokine production via the lXrα pathway
To test whether NFκB activation involved in the antiinflammatory effects of anthocyanins is mediated by the LXRα pathway, we next detected the expression of NFκB p65 when LXRα was silenced in HK-2 cells using pLV-NR1H3-shRNA plasmid. As expected, the inhibitory effect of anthocyanins on NFκB activity was reversed markedly by transfection with pLV-NR1H3-shRNA ( Figure 10A ). We then used immunocytochemistry to investigate the nuclear translocation of NFκB p65. Data revealed that NFκB p65 was localized predominately in the cytoplasm in control cells, whereas HG treatment caused pronounced NFκB p65 nuclear staining. However, C3G and Cy decreased the nuclear distribution of NFκB p65 ( Figure 10B ). Moreover, transfection with pLV-NR1H3-shRNA led to predominantly nuclear NFκB p65 staining after HG treatment. Taken together, these data suggest that anthocyanins inhibit HG-induced inflammatory gene expression by activating LXRα and affecting the nuclear translocation of NFκB.
Discussion
The drugs used to treat diabetes and its complications often cause a variety of side effects. Therefore, increasing attention has focused on studying phytochemicals that are easy to obtain and lack numerous side effects. 27 Anthocyanins are naturally occurring phytochemicals and are widely distributed in vegetables, fruits, and grains; therefore, a high daily intake (180-250 mg/day) can be achieved from plant-based diets. Glycosides of aglycon cyanidin are the most abundant anthocyanin, and cyanidin might be obtained from cyanidin-glycosides via bacterial β-glycosidase-catalyzed hydrolysis. 32 Hou et al 33 reported that cyanidin and cyanidin-glycosides have antioxidant properties in living systems. Recently, several studies demonstrated that C3G has potential antidiabetic and anti-inflammatory effects. [34] [35] [36] However, it was unclear whether cyanidin has similar effects. Therefore, we assessed the effects of C3G and Cy on HG-induced cholesterol accumulation and inflammation in HK-2 cells. Data revealed that C3G and Cy decreased cholesterol accumulation by activating PPARα and LXRα to increase the expression of ABCA1. In addition, C3G and Cy inhibited the production of the proinflammatory cytokines MCP1, ICAM1, and TGFβ1 by activating LXRα and inhibiting the nuclear translocation of NFκB. These results suggest that anthocyanins might have important implications toward preventing diabetes-associated kidney injury.
Recent work suggested that decreased cellular cholesterol efflux contributes to the progression of DN. Renal cholesterol accumulation was reported in podocytes, 37 diabetic NOD mice, 16 and an animal model of acute renal tubular injury.
17 ABCA1 is a well-characterized cholesterol transporter that regulates cellular lipid homeostasis. 16, 17 Some reports showed that anthocyanins significantly ameliorated hypercholesterolemia and suppressed cholesterol accumulation by upregulating ABCA1 in the liver and aorta, suggesting the anthocyanins might remove cholesterol from tissues. 29, 30 Preclinical studies revealed that dietary anthocyanin-rich extracts ameliorated hyperglycemia and hyperlipidemia in high-fructose-fed rats and experimental type 2 diabetic mice. 38, 39 Here, we showed that HG inhibited cholesterol efflux and increased the intracellular cholesterol content in HK-2 cells significantly, which was accompanied by reduced ABCA1 expression. C3G and Cy treatment reversed these effects: increased ABCA1 mRNA and protein expression and intracellular cholesterol efflux were observed in HK-2 cells cotreated with HG and anthocyanins.
The levels of proinflammatory cytokines such as ICAM1, MCP1, and TGFβ1 are elevated in diabetic kidneys, suggesting that renal inflammation might contribute to the pathogenesis of DN. [6] [7] [8] [9] Recent studies focused on the anti-inflammatory properties of anthocyanins for application in a large number of inflammatory diseases. C3G inhibited the expression of TNFα, IL1β, IL6, IL10, and IFNβ in LPS-stimulated alveolar inhibited the production of MCP1, ICAM1, and TGFβ1 both intracellularly and extracellularly. NFκB is an important transcription factor that plays a critical role in inducing cytokine production;
22 the anthocyanin-mediated inhibition of HG-induced cytokine production was likely mediated by the NFκB pathway. macrophages in a model of acute lung injury. 40 In addition, PCA inhibited MCP1 expression and attenuated the induction of ICAM1 to ameliorate the diabetic state in diabetic kidneys. 41 PCA also retarded diabetes-associated renal fibrosis and mesangial inflammation by disturbing TGFβ1 signaling. 8 This study revealed that C3G and Cy 
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Protective effects of anthocyanins in diabetic nephropathy Nuclear LXR, and particularly LXRα, is an extensively studied and validated gene whose primary function is to maintain cellular cholesterol homeostasis. 18, 19 LXRα regulates intracellular cholesterol levels by mediating the expression of its target gene ABCA1 by binding to an LXR element in the ABCA1 promoter. 42 In addition to LXRα, the nuclear receptor superfamily member PPARα plays a critical role in lipid metabolism and regulates the expression of ABCA1. 18, 19 The activation of PPARα reduces triglyceride, total cholesterol, and LDL levels markedly, and consequently elevates HDL levels. 43 Moreover, previous studies demonstrated that crosstalk occurs between PPARα and LXRα during the regulation of cholesterol efflux and that PPARα induces LXRα expression directly via a response element upstream of the LXRα promoter region. This leads to the induction of ABCA1, followed by a transcriptional cascade that regulates cholesterol removal from macrophages. 18, 19 In addition, PPARα agonists induce ABCA1 expression and cholesterol efflux in macrophages in an LXRα-dependent manner. 22, 23 To investigate the molecular mechanisms by which C3G and Cy increased intracellular cholesterol efflux and ABCA1 expression in HK-2 cells, we measured their effects on PPARα and LXRα activation in the presence and absence of GW6471, a PPARα inhibitor, and pLV-NR1H3-shRNA, an LXRα silencing plasmid. Data revealed that C3G and Cy increased PPARα and LXRα expression. In addition, GW6471 and LXRα shRNA abolished the anthocyanin-mediated increase in cholesterol efflux and ABCA1 expression. Moreover, GW6471 also attenuated anthocyanin-mediated LXRα expression significantly. In contrast, LXRα shRNA did not affect anthocyanin-induced PPARα expression. Therefore, these combined findings illustrate a complex pathway involving PPARα, LXRα, and ABCA1 that participates in the anthocyanin-mediated increase in cholesterol efflux from HK-2 cells.
Accumulating evidence suggests that PPARα and LXRα also play an anti-inflammatory role in many inflammatory and metabolic diseases. 22, 35 Our previous experiments demonstrated that anthocyanin inhibited the production of proinflammatory cytokines. Therefore, we detected the effects of GW6471 and pLV-NR1H3-shRNA plasmid on the anthocyanin-mediated decrease in the proinflammatory cytokines MCP1, ICAM1, and TGFβ1 to further confirm whether PPARα and LXRα are involved in the anti-inflammatory effects of anthocyanins in HK-2 cells. Silencing LXRα using pLV-NR1H3-shRNA reversed the effects of C3G and Cy on HG-induced MCP1, ICAM1, and TGFβ1 expression. However, the PPARα antagonist GW6471 did not have the same effect; therefore, we conclude that C3G
and Cy reduce HG-induced MCP1, ICAM1, and TGFβ1 expression partly by activating LXRα, but not PPARα, in HK-2 cells.
However, additional results showed that the anthocyanininduced inhibition of HG-induced cytokine production was likely mediated by the NFκB pathway. To further confirm the interrelationship between LXRα and NFκB in anthocyanin-mediated decreased cytokine expression, we assessed NFκB activation when LXRα was silenced using pLV-NR1H3-shRNA. These results demonstrated that C3G and Cy inhibited HG-induced NFκB nuclear translocation markedly, and that this effect was largely abolished when LXRα was silenced using pLV-NR1H3-shRNA. This result is consistent with previous studies reporting that the inhibition of inflammatory gene expression using LXR agonists involves antagonizing NFκB signaling. 44, 45 Taken together, these results suggest that the anti-inflammatory effects of the anthocyanins C3G and Cy in HK-2 cells are partly mediated by inhibiting the LXRα-stimulated nuclear translocation of NFκB, which further decreases the levels of the proinflammatory cytokines MCP1, ICAM1, and TGFβ1.
In conclusion, this study demonstrated that anthocyanins modulate cholesterol metabolism and the inflammatory response in HG-stimulated HK-2 cells, suggesting that anthocyanins might have novel therapeutic effects in DN. In addition, C3G and Cy had similar antihyperlipidemic and anti-inflammatory properties. Therefore, we hypothesize that the antihyperlipidemic and anti-inflammatory activities are due to their aglycone moiety. However, more work is needed to clarify the structure-function relationship and the effects of anthocyanins.
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